Bodisen Biotech, Top-Wachstum und Hochprofitabel. Schlagt zu - 500 Beiträge pro Seite

[PanTau]

Hallo Leute,

bin vor einiger Zeit auf den Wert Bodisen Biotech aufmerksam geworden. Ist keine klassische Biotech-Firma wie es der Name vermuten läasst. Die Firma ist in China im Bereich Mischdünger, Flüssigdünger oder Pestizide ökologischer Basis tätig. Firma expandiert derzeit nach Malaysia, Indonesien, Thailand...Australien usw. Wird an der AMEX gehandelt mit dem Ticker BBC. Kurs ist schon etwas angelaufen, aber meines Erachtens ist der Titel deutlich unterbewertet. Ich selbst besitze noch keine Aktien.

Was denkt ihr, ist es ein mittelfrist-Investment wert???

[corawuff]

bin schon seit über einem jahr dort investiert, wenn du kaufen willst lieber nicht in deutschland, da findet im prinzip kein handel statt

[bobelle]

Zum Glück, sind wir schon daei!

Bodisen Says Trade Show Orders Rise
Tuesday December 6, 9:36 am ET
Bodisen Biotech Says November Trade Shows Yielded $43 Million in Contracts

NEW YORK (AP) -- Bodisen Biotech Inc., a Chinese manufacturer of organic fertilizers, said Tuesday that it received 2006 orders worth $43 million from November trade shows and it expects "record" earnings.

The company`s shares jumped $1.30, or 12.2 percent, to $12 in morning trading on the American Stock Exchange.

Bodisen said the contracts are more than double the $20 million it received at China trade shows last year. The company posted $16.2 million in sales for 2004.

Bodisen said it expects "record" fourth-quarter and 2006 earnings on growth from current product lines and a favorable market. The company said it is experiencing more than 30 percent profit margins across most of its products lines, on average.

[Braggo2]

http://www.wallstreet-online.de/ws/community/board/threadpag…

[Buddah]

interessanter Wert!


gruss b.

[bobelle]

Guter Artikel zu Bodisen:

Motley Fool
Big Organic Growth in China
Tuesday December 6, 4:01 pm ET
By W.D. Crotty

When I see BBC, I think of the British Broadcasting corporation. But that stock symbol belongs to Bodisen Biotech (AMEX: BBC - News), and it`s making news today as the largest percentage gainer on the AMEX.

Bodisen is a Chinese pesticide and bio-fertilizer company. What has launched this stock more than 20% to a new 52-week high? $43 million in orders at two recent trade shows, for starters. Last year, the company booked $20 million in orders at these shows, and it has trailing annual revenue of $28 million. So to an extent, at this company`s fledgling stage in its lifecycle, the trade shows produce good visibility of the company`s year-ahead revenue potential.

Bodisen is a company in the right place at the right time. China, the exporter to the world, is a large importer of grains and food. The Chinese government has mandated that farmers increase crop yields to decrease the nation`s dependence on foreign imports.

Bodisen`s products are based on proprietary agricultural technology jointly developed by company scientists and university laboratories. Their fertilizers appeal to farmers because their use allows the crops to be labeled as organically grown and, in China as in the United States, that label generally means higher prices. The company expects its organic growth to continue as it gains market share at the expense of chemical fertilizer companies.

Revenue for the first nine months skyrocketed 100% year over year, and net income soared 64% to $0.41 a fully diluted share. The one analyst who follows the company expects it to earn $0.51 this year and $0.87 next year. That prices the stock at a reasonable 15 times 2006 earnings.

As Motley Fool readers know, a number of Chinese growth companies are not priced at outrageous levels. Motley Fool Rule Breaker picks Shanda Interactive (Nasdaq: SNDA - News) and NetEase (Nasdaq: NTES - News) are priced, respectively, at 12.8 and 14.4 times 2006 earnings. Only Motley Fool Stock Advisor recommendation Sina (Nasdaq: SINA - News), which changes hands at 24.7 times forward earnings, trades at a P/E close to its five-year annual growth rate of 30%.

Forbes China ranked Bodisen as one of the Top 100 growth companies in China earlier in 2005, and that just might continue to be the case. While any investor in China needs to be concerned about governmental mandates, Biodisen appears to have the wind to its back. But at 5.9 times trailing sales, the company needs to maintain its margins and growth to continue its smooth sailing on Wall Street. Investors also need to be aware that the Chinese government might not extend the company`s current tax exemption, which expires in 2007. It also bears mentioning that the company currently occupies only 0.5% of the Chinese fertilizer market and competes against the likes of chemical fertilizer giants Dow Chemical (NYSE: DOW - News), a Motley Fool Income Investor pick, and DuPont (NYSE: DD - News) -- both of which represent potentially weighty barriers to continued and profitable expansion.

To the extent that Chinese producers and customers find value in organic goods, and the absence of meaningful competition in China, this might continue to be a worthwhile growth story. But further expansion will likely depend upon continued and significant wealth creation in China. In the wealthy U.S., organic goods are a sort of luxury item, and it`s logical that they`d be even more so in China.

[Braggo2]

Ja, das KUV wird als Problem gesehen, weil das nur gerechtfertigt ist, wenn die Gewinnmargen gehalten werden können. Daher wohl auch der Kursrückgang heute
Das mag langfristig sein, aber kurzfristig ist das Momentum auf der Seite von Bodisen. Der Darvas-Investor www.darvas-investor.de hält die Aktie auf jeden Fall weiter im Musterdepot.

Positiv auch diese Meldung von heute. Investor Relations-Anstrengungen werden weiter verstärkt um institutionelle Investoren anzulocken:

Bodisen Biotech Retains The Piacente Group as U.S. Investor Relations Counsel
WEDNESDAY, DECEMBER 07, 2005 8:00 AM
- BusinessWire




BBC
12.06 -0.62





Enter Symbol:



Enter Keyword:



NEW YORK, Dec 07, 2005 (BUSINESS WIRE) -- Bodisen Biotech, Inc. (BBC) , the first China based environmentally friendly bio fertilizer company listed on a U.S. stock exchange, announced today that it has retained The Piacente Group, Inc., a New York City headquartered investor relations and financial communications consulting firm, to provide strategic investor relations services.

Ms. Qiong Wang, CEO of Bodisen commented, "Our partnership with The Piacente Group will assist in the implementation of our strategic communications plans as we broaden our relationship and awareness with investment firms and institutional investors in the capital markets. We believe The Piacente Group has the right track record and leadership position of working with some of the most well-known China-based companies and producing solid results to enhance shareholder value for its clients. Bodisen highly appreciates Piacente`s rigorous client selection process which is based on quality of companies and not on quantity. Bodisen will rely heavily on the expertise of The Piacente Group to provide strategic investor relations for our company as we continue to experience rapid earnings growth."

Brandi Piacente, President of The Piacente Group stated, "We are excited to work with Bodisen. Having worked closely with some of the leading companies in China, we believe we have developed the right approach to investor relations that will produce targeted results for Bodisen and its shareholders. We maintain a high standard when selecting new clients to represent in the capital markets and feel strongly that Bodisen`s healthy business model, impressive track record of delivering financial and operating results, and heavy demand for its environmental products will be a winning combination for increased growth of its business and successful execution of its long term strategic plans."

About Bodisen Biotech, Inc.

A Delaware company, Bodisen is headquartered in Shaanxi, China`s agricultural hub. The Bodisen brand is a highly recognized fertilizer brand in China. Its environmentally friendly "green" products support the mandate of the Chinese government to increase crop yields for the purpose of decreasing China`s dependency on food imports. Among China`s population of 1.3 billion, approximately 900 million are farmers whose incomes depend on their crop yields.

With over 60 products and approximately 600 (and growing) nationwide distribution centers, Bodisen has experienced rapid growth. Bodisen`s products are based on proprietary agricultural technology jointly developed by company scientists and university laboratories. These products address grains, vegetables, and fruit crops and have been proven to increase crop yields by 10% to 35% while being 100% environmentally friendly.

About The Piacente Group, Inc.

The Piacente Group, Inc. is an investor relations and financial communications consulting firm based in New York with offices in San Francisco, Beijing and Guangzhou, China. With a focused approach on developing integrated strategic solutions to a company`s investor relations program, The Piacente Group`s main objectives are to increase visibility to investors and deliver enhanced shareholder value to its diversified base of high quality clients. The Piacente Group is dedicated to providing its clients customized solutions in a dynamic investment environment. For more information, please visit www.tpg-ir.com.

SOURCE: Bodisen Biotech, Inc.